PAUL HAVRILKA: Open Payments
NPI 1801071543 · CENTRALIA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,355 in 78 payments from 18 companies in 2025. Trend: 2023 $1,296 · 2024 $1,452 · 2025 $1,355
Food & beverage: $1,355
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $310 |
| AstraZeneca Pharmaceuticals LP | 14 | $240 |
| ABBVIE INC. | 11 | $175 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $117 |
| Lilly USA, LLC | 4 | $90 |
| Axsome Therapeutics, Inc. | 4 | $78 |
| Aimmune Therapeutics, Inc. | 2 | $44 |
| Amgen Inc. | 2 | $40 |
| Viatris Specialty LLC | 2 | $39 |
| Lundbeck LLC | 2 | $38 |
Products named: QULIPTA, Wegovy, Kerendia, FASENRA, FARXIGA, BREZTRI, MOUNJARO, Sunosi.
Industry payments across IL — which companies pay providers there.
